Page 36 - Revista Portuguesa de Buiatria - Nº 22

muito positiva ao nível da diminuição das CS no Gomes F, Saavedra MJ, Henriques M. 2016. Bovine mastitis
leite das vacas afetadas, tal como o protocolo disease/pathogenicity: evidence of the potential role of
apenas IMM com duração de sete dias. Estes microbial biofilms. Coenye T, editor. Pathog Dis. 74(3).
apresentam uma taxa de cura razoável, porém o Heikkilä AM, Liski E, Pyörälä S, Taponen S. 2018. Pathogen-
-specific production losses in bovine mastitis. J Dairy Sci.
tratamento IMM de cinco dias demonstrou -se in- 101(10):9493-9504.
suficiente, com valores de CCS elevados. A pari- Hillerton JE, Kliem KE. 2002. Effective treatment of Strepto-
dade do animal poderá ter tido alguma influência coccus uberis clinical mastitis to minimize the use of an-
nas taxas de cura atingidas, uma vez que animais tibiotics. J Dairy Sci. 85(4):1009-1014.
multíparos apresentaram taxas mais baixas. Após Jayarao BM, Gillespie BE, Lewis MJ, Dowlen HH, Oliver SP.
1999. Epidemiology of Streptococcus uberis intra-
a aplicação das diferentes terapias foi visível ain- mammary infections in a dairy herd. J Vet Med Ser B.
da uma diminuição nas CS presentes no leite, 46(7):433-442.
embora se mantenham em valores elevados. Kalmus P, Simojoki H, Orro T, Taponen S, Mustonen K, Ho-
Em suma, é muito importante conhecer o lopainen J, Pyörälä S. 2014. Efficacy of 5 -day parenteral
agente etiológico aquando do diagnóstico de uma versus intramammary benzylpenicillin for treatment of
clinical mastitis caused by gram -positive bacteria suscep-
mamite. No entanto, as recomendações quanto tible to penicillin in vitro. J Dairy Sci. 97(4):2155-2164.
ao tratamento a aplicar devem ser baseadas tam- Khan IU, Hassan AA, Abdulmawjood A, Lämmler C, Wolter
bém nas caraterísticas de cada animal. Informa- W, Zschöck M. 2003. Identification and epidemiological
ções como a paridade, a fase de lactação e o characterization of Streptococcus uberis isolated from
historial a nível de CCS do animal poderão auxiliar bovine mastitis using conventional and molecular me-
thods. J Vet Sci. 4(3):213 -223.
na escolha da duração da terapia, permitindo um Klaas IC, Zadoks RN. 2018. An update on environmental mas-
prognóstico mais realista e, desta forma, um cus- titis: Challenging perceptions. Transbound Emerg Dis.
to mais fundamentado para o produtor. 65(April 2017):166-185.
Kromker V, Reinecke F, Paduch J -H, Grabowski N. 2014. Bo-
vine Streptococcus uberis Intramammary Infections and
Mastitis. Clinic Microbiol. 3(4).
Referências Bibliográgicas Leigh JA. 1999. Streptococcus uberis: A permanent barrier to
the control of bovine mastitis? Vet J. 157(3):225-238.
Archer SC, Bradley AJ, Cooper S, Davies PL, Green MJ. 2017. Lopez -Benavides MG, Williamson JH, Pullinger GD, Lacy-
Prediction of Streptococcus uberis clinical mastitis risk -Hulbert SJ, Cursons RT, Leigh JA. 2007. Field observations
using Matrix -assisted laser desorption ionization time of on the variation of streptococcus uberis populations in a
flight mass spectrometry (MALDI -TOF MS) in dairy herds. pasture -based dairy farm. J Dairy Sci. 90(12):5558-5566.
Prev Vet Med. 144:1-6. Milne MH, Biggs AM, Barrett DC, Young FJ, Doherty S, Inno-
Blowey RW, Edmondson P. 2010. Mastitis Control in Dairy cent GT, Fitzpatrick JL. 2005. Treatment of persistent in-
Herds. 2ª edição. United Kingdom (GB): CAB tramammary infections with Streptococcus uberis in dairy
International. cows. Vet Rec. 157(9):245-250.
Bradley AJ. 2002. Bovine mastitis: An evolving disease. Vet Paduch JH, Mohr E, Krömker V. 2013. The association bet-
J. 164(2):116-128. ween bedding material and the bacterial counts of Sta-
Bramley AJ, Dodd FH. 1984. Reviews of the progress of dairy phylococcus aureus, Streptococcus uberis and coliform
science: mastitis control–progress and prospects. J Dairy bacteria on teat skin and in teat canals in lactating dairy
Res. 51(3):481-512. cattle. J Dairy Res. 80(2):159-164.
Breen J, Hudson C, Green M, Bradley A. 2011. Combination Patel D, Almeida RA, Dunlap JR, Oliver SP. 2009. Bovine
therapy for mastitis in dairy herds: evidence and research. lactoferrin serves as a molecular bridge for internalization
Vet Times. 41(20):8 -12. of Streptococcus uberis into bovine mammary epithelial
Collado R, Montbrau C, Sitjà M, Prenafeta A. 2018. Study of the cells. Vet Microbiol. 137(3-4):297-301.
efficacy of a Streptococcus uberis mastitis vaccine against Pullinger GD, López -Benavides M, Coffey TJ, Williamson JH,
an experimental intramammary infection with a heterologous Cursons RT, Summers E, Lacy -Hulbert J, Maiden MC,
strain in dairy cows. J Dairy Sci. 101(11):10290-10302. Leigh JA. 2006. Application of Streptococcus uberis mul-
Constable PD, Hinchcliff KW, Done SH, Grunberg W. 2017. tilocus sequence typing: Analysis of the population struc-
Veterinary medicine: A textbook of the diseases of cattle, ture detected among environmental and bovine isolates
sheep, pigs, goats and horses. 11ª edição. Missouri (MO): from New Zealand and the United Kingdom. Appl Environ
Elsevier. Capítulo 20, Diseases of the mammary gland; p. Microbiol. 72(2):1429-1436.
1904-2001. Pyörälä S. 2009. Treatment of mastitis during lactation. Ir Vet
Deluyker HA, Van Oye SN, Boucher JF. 2005. Factors affec- J. 62(4):40-44.
ting cure and somatic cell count after pirlimycin treatment Rato MG, Bexiga R, Nunes SF, Cavaco LM, Vilela CL, Santos-
of subclinical mastitis in lactating cows. J Dairy Sci. -Sanches I. 2008. Molecular epidemiology and population
88(2):604-614. structure of bovine Streptococcus uberis. J Dairy Sci.
Douglas VL, Fenwick SG, Pfeiffer DU, Williamson NB, Holmes 91(12):4542-4551.
CW. 2000. Genomic typing of Streptococcus uberis iso- Samson O, Gaudout N, Schmitt E, Schukken YH, Zadoks R.
lates from cases of mastitis, in New Zealand dairy cows, 2016. Use of on -farm data to guide treatment and control
using pulsed -field gel electrophoresis. Vet Microbiol. mastitis caused by Streptococcus uberis. J Dairy Sci.
75(1):27-41. 99(9):7690-7699.

34